Tag: pediatric vaccine market trends

  • Pediatric Vaccine Market Growth Potential: Key Insights for 2024-2033

    Pediatric Vaccine Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Will the Pediatric Vaccine Market Grow from 2024 to 2033?

    The market size for pediatric vaccines has seen robust growth lately. It’s expected to surge from $49.89 billion in 2023 to $53.52 billion in 2024, representing a compound annual growth rate (CAGR) of 7.3%. Factors which have contributed to the surge during the historic period include the rise in chronic diseases, policies designed to eliminate endemic diseases through immunization, and increased funding geared toward vaccine development.

    A significant expansion is anticipated in the pediatric vaccine market over the forthcoming years. Projections indicate that this market will swell to $83.49 billion by 2028, demonstrating an 11.8% compound annual growth rate (CAGR). This projected progression over the forecast period can be linked to the increasing incidence of invasive cervical cancer, a robust late-stage pipeline and approvals for new drugs, as well as an increasing prevalence of infectious diseases. In this forecast period, the market is expected to evolve with trends such as the development of combination vaccines to fulfill market demand, investment in research and development activities for the production of effective vaccines, development of vaccines targeting the younger demographic, focus on creating live attenuated vaccines for long-term immune protection of patients, usage of novel immunoengineering and advanced delivery systems for vaccine formulation to improve safety, and integration of artificial intelligence (AI) in vaccine development to streamline production processes.

    Claim Your Free Sample of the Global Pediatric Vaccine Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

    What Aspects Are Influencing the Growth Rate of the pediatric vaccine Market?

    The mounting instances of chronic diseases such as tuberculosis, diphtheria, and pneumonia among children below 15 years are set to bolster the growth of the pediatric vaccines market. The severity and complications of infectious diseases are escalating among children and teens grappling with chronic conditions. In March 2022, the Australian Bureau of Statistics, a self-governing Australian entity in-charge of collecting and analyzing data, reported that about half of the total population (46.6%, or 11.6 million) possessed at least one chronic disease. With the increased prevalence of these diseases among children, the demand for immunization against them spikes, thereby fuelling the growth of the pediatric vaccine market.

    What Are the Critical Segments of the Pediatric Vaccine Market?

    1) By Vaccine Type: Monovalent, Multivalent

    2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

    3) By Application: Infectious Disease, Allergy, Cancer

    What Trends Are Redefining Consumer Expectations in the Pediatric Vaccine Market?

    The push for innovative vaccines continues to surge as a response to the pressing need for more efficient immunization against formidable infectious diseases, such as tuberculosis and HIV/AIDS, along with non-communicable chronic diseases like cancer and neurodegenerative diseases. This innovation involves elements like structural immunogenic design, gene-oriented vaccine platforms, and potent adjuvant recombinant antigen formulas. Consequently, manufacturers and developers of pediatric vaccines are persistently in the hunt for cutting-edge design and production technologies to keep up with this escalating demand. An example of this was seen in April 2023 when Pfizer Inc., an American pharmaceutical manufacturing company, publicized that they received U.S. FDA approval for REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine suitable for children and infants.

    Order Now for Fast Delivery of Your Pediatric Vaccine Market Report!

    https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

    What Are the Leading Regions in the Pediatric Vaccine Market Expansion?

    North America was the largest region in the pediatric vaccine market in 2023. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Pediatric Vaccine Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pediatric vaccine market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Pediatric Vaccine Market Include

    1. Pediatric Vaccine Market Executive Summary

    2. Pediatric Vaccine Market Segments

    3. Pediatric Vaccine Market Size And Template Market Growth Rate

    4. Key Pediatric Vaccine Market Trends

    5. Major Pediatric Vaccine Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Pediatric Vaccine Market

    26. Top Pediatric Vaccine Companies

    27. Pediatric Vaccine Market Opportunities And Strategies

    28. Pediatric Vaccine Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Patient Blood Management Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

    DTP Vaccines Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

    Vaccines Global Market Report 2022

    https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Pediatric Vaccine Market 2024: Size, Drivers, And Trends

    Overview Of The Pediatric Vaccine Market 2024: Size, Drivers, And Trends

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Pediatric Vaccine Global Market Report 2024, the pediatric vaccine market is expected to show promising growth in the forecast period.

    The pediatric vaccine market has witnessed robust growth in recent years, with significant expansion anticipated in the coming years.

    • Current Market Size: $49.89 billion in 2023, expected to reach $53.52 billion in 2024.
    • Compound Annual Growth Rate (CAGR): 7.3% from 2023 to 2024.
    • Forecasted Growth: Expected to soar to $83.49 billion by 2028, at a CAGR of 11.8%.

    Factors Driving Growth
    Several key factors contribute to this growth trend, both historically and in the forecasted period.

    • Increased Prevalence of Chronic Diseases: Such as tuberculosis, diphtheria, and pneumonia.
    • Immunization Policies: Efforts to eradicate endemic diseases through vaccination.
    • Rising Funding for Vaccine Development: Facilitating innovation and accessibility.

    Understanding Market Dynamics
    Impact of Chronic Diseases on Market Growth
    The escalating prevalence of chronic diseases among children is a significant driver of market growth.

    • Australian Statistics: In March 2022, 46.6% of Australia’s population had at least one chronic condition.
    • Demand for Immunization: Rise in demand for vaccines targeting chronic diseases among children and adolescents.

    View More On The Pediatric Vaccine Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

    Noteworthy Companies
    Several key players are shaping the landscape of the pediatric vaccine market.

    • Merck & Co. Inc.
    • Serum Institute of India Pvt. Ltd.
    • Sanofi SA
    • Pfizer Inc.
    • AstraZeneca
    • GlaxoSmithKline PLC

    Recent Developments
    FDA Approval Milestone
    Recent FDA approvals mark significant milestones in pediatric immunization efforts.

    • ABRYSVO Approval: Authorized for use in pregnant women to prevent lower respiratory tract diseases in infants.
    • Pfizer’s Initiative: FDA approval for ABRYSVO to prevent respiratory syncytial virus (RSV) in infants.

    Market Segmentation
    Understanding the segmentation of the pediatric vaccine market provides insights into its diverse landscape.

    • Vaccine Types: Monovalent, Multivalent
    • Technological Approaches: Live Attenuated, Inactivated, Toxoid, Conjugate, Others
    • Applications: Infectious Disease, Allergy, Cancer

    Regional Insights
    Regional dynamics play a crucial role in shaping the pediatric vaccine market landscape.

    • North America: Emerged as the largest region in the market in 2023.
    • Middle East: Expected to witness significant growth, becoming the largest growing region during the forecast period.

    Future Trends
    Anticipated trends offer a glimpse into the future trajectory of the pediatric vaccine market.

    • Combination Vaccines: Development to meet market demand.
    • R&D Investments: Focus on developing effective vaccines.
    • Live Attenuated Vaccines: Increasing emphasis on this approach.
    • Advanced Delivery Systems: Utilizing new immune engineering for enhanced efficacy.
    • AI Integration: Simplifying vaccine development and manufacturing processes.

    Conclusion
    The pediatric vaccine market is on a robust growth trajectory, driven by various factors such as the rising prevalence of chronic diseases, increased funding for vaccine development, and innovative approaches by key players. With promising forecasts and ongoing advancements, the future of pediatric immunization appears bright, ensuring better health outcomes for children worldwide.

    Request A Sample Of The Global Pediatric Vaccine Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=2824&type=smp